375 related articles for article (PubMed ID: 18173752)
1. Considerations in the approach to invasive fungal infection in patients with haematological malignancies.
Bow EJ
Br J Haematol; 2008 Jan; 140(2):133-52. PubMed ID: 18173752
[TBL] [Abstract][Full Text] [Related]
2. [Mycoses and their treatment in malignant hemopathies].
Martino P; Girmenia C
Recenti Prog Med; 1999 Mar; 90(3):160-8. PubMed ID: 10228357
[TBL] [Abstract][Full Text] [Related]
3. [Invasive fungal infections in patients with hematological malignancies: a clinical approach].
García-Ruiz JC; Pontón J
Med Clin (Barc); 2000 Sep; 115(8):305-12. PubMed ID: 11093887
[No Abstract] [Full Text] [Related]
4. Management of intracranial fungal infections in patients with haematological malignancies.
Mattiuzzi G; Giles FJ
Br J Haematol; 2005 Nov; 131(3):287-300. PubMed ID: 16225648
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
[TBL] [Abstract][Full Text] [Related]
6. Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies.
Murali S; Langston A
Transpl Infect Dis; 2009 Dec; 11(6):480-90. PubMed ID: 19725908
[TBL] [Abstract][Full Text] [Related]
7. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
Ruhnke M; Maschmeyer G
Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy.
Cornely OA; Aversa F; Cook P; Jones B; Michallet M; Shea T; Vallejo C
Eur J Haematol; 2011 Oct; 87(4):289-301. PubMed ID: 21752098
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy.
Pagano L; Caira M; Fianchi L
Ann Med; 2005; 37(4):259-69. PubMed ID: 16019724
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
Vardakas KZ; Michalopoulos A; Falagas ME
Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
[TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
Fung M; Kim J; Marty FM; Schwarzinger M; Koo S
PLoS One; 2015; 10(11):e0140930. PubMed ID: 26554923
[TBL] [Abstract][Full Text] [Related]
13. [Early diagnosis of invasive fungal infections in hematooncological patients by serological methods].
Rácil Z; Kocmanová I; Wagnerová B; Lengerová M; Mayer J
Vnitr Lek; 2007 Sep; 53(9):990-9. PubMed ID: 18019671
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in the management of invasive fungal infections in patients with hematological malignancies.
Karthaus M; Cornely OA
Ann Hematol; 2005 Apr; 84(4):207-16. PubMed ID: 15614521
[TBL] [Abstract][Full Text] [Related]
15. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
Rogers TR; Slavin MA; Donnelly JP
Br J Haematol; 2011 Jun; 153(6):681-97. PubMed ID: 21504422
[TBL] [Abstract][Full Text] [Related]
16. Invasive infection due to Trichosporon cutaneum in patients with hematologic malignancies.
Kataoka-Nishimura S; Akiyama H; Saku K; Kashiwa M; Mori S; Tanikawa S; Sakamaki H; Onozawa Y
Cancer; 1998 Feb; 82(3):484-7. PubMed ID: 9452265
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.
Hoenigl M; Zollner-Schwetz I; Sill H; Linkesch W; Lass-Flörl C; Schnedl WJ; Krause R
Mycoses; 2011 Sep; 54(5):454-9. PubMed ID: 20406398
[TBL] [Abstract][Full Text] [Related]
18. [Prophylaxis of fungal infections in haematological patients: contra].
Schwartz S
Dtsch Med Wochenschr; 2010 Sep; 135(38):1871. PubMed ID: 20842608
[No Abstract] [Full Text] [Related]
19. Mucormycosis-associated fungal infections in patients with haematologic malignancies.
Kara IO; Tasova Y; Uguz A; Sahin B
Int J Clin Pract; 2009 Jan; 63(1):134-9. PubMed ID: 17362481
[TBL] [Abstract][Full Text] [Related]
20. Microbiologic consequences of new approaches to managing hematologic malignancies.
Blijlevens NM; Donnelly JP; de Pauw BE
Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]